Диссертация (1145009), страница 67
Текст из файла (страница 67)
Santoliquido, F. Cremonini //Eur. Heart J. – 2004. – N 25. – P. 64-68.290. Galis Z. Increased expression of matrix metalloproteinases and matrix degradingactivity in vulnerable regions of human atherosclerotic plaques / Z. Galis, G.Suknove, M. Lark, P. Libby // J. Clin. Invest. – 1994. – N 94. – P. 2493-503.291.
Gawaz M. Platelets in the onset atherosclerosis. Blood Cells, Molecules, and Diseases / M. Gawaz // – 2006. – Vol. 36, N 2. – P. 206-210.292. Genta R.M. The immunobiology of Helicobacter pylori gastritis / R.M. Genta //Semin. Gastrointest. Dis. – 1997. – N 8. – P. 2-11.293. George J. Anti-oxidized on density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty / J.George, D. Harats, E. Bakshi et all // Immunol. Lett. – 1999. – Vol.
68, N 2-3. – P.263-66.294. George J. Enhanced fatty steak formation in C57BL/6J mice by immunization withheat shoock protein – 65 / J. George, Y. Shoenfeld, A. Afek, B. Gilburd et all //Arterioscler. Tromb. Vasc.Biol. – 1999. – N 19. – P. 505-10.295. Ghirardi G. Helicobacter pylori detected in atheroma plaque / G. Ghirardi, F. Maldonado, L. Guzmán et all // Rev. Fac. Cien. Med. Univ. Nac. Cordoba. – 2006. – N63.
– P. 17-23.383296. Gisbert J.P. Value quantitative serology for conformation of Helicobacter pylorieradication / J.P. Gisbert, М. Blanco, L. Benito et all // Clin. Infect. Dis. – 2000. – N30. – P. 976-80.297. Glovinska B. Selected cytokines (IL-6, IL-8, IL-10, MCP-1, TNF-alfa) in childrenwith atherosclerosis risk factors: obesity, hypertension, diabetes / B. Glovinska, M.Urban // Wiad. Lek.
– 2003. – Vol. 56, N 3-4. – P. 109-16.298. Go M.F. Virulence and pathogenicity of Helicobacter pylori / M.F. Go, S.E. Crowe// Gastroenterology Clinics. – 2000. – Vol. 29, N 3. – P. 123-30.299. Goldberg R.J. Trends in community mortality due to coronary heart disease / R.J.Goldberg, К. Glatfelter, Е. Burbank-Schmidt et all // Am. Heart J. – 2006. – Vol.151, N 2. – P. 501-07.300. Grayston J.T. Background and current knowledge of Chlamydia pneumoniae andatherosclerosis / J.T. Grayston // J.
Infect. Dis. – 2000. – N 181 (Suppl. 3). – P.S402-S410.301. Gredmark S. Human cytomegalovirus inhibits cytokines-induced macrophage differentiation / S. Gredmark, T. Tilburgs, C. Soderberg-Naucler // J. Virol. – 2004. –N 78. – P. 10378-89.302. Gredmark-Russ S. Active cytomegalovirus infection in aortic smooth muscle cellsfrom patients with abdominal aortic aneurysm / S. Gredmark-Russ, M.
Dzabic, A.Rahbar et all // J. Mol. Med. (Berl). – 2009. – Vol. 87, N 4. – P. 347-56.303. Guetta E. Monocytes harboring cytomegalovirus: interactions with endothelialcells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury / E.Guetta, V. Guetta, T. Shibutani, S.E. Epstein // Circ. Res. – 1997. – Vol.
81, N 1. –P. 8-16.304. Gunn M. Significant association of cagA positive Helicobacter pylori strains withrisk of premature myocardial infarction / M. Gunn, J.C. Stephens, J.R. Thompson etall // Heart. – 2000. – Vol. 84, N 3. – P. 267-71.384305. Guo F.H. Cross-reactivity of anti-H.pylori antibodies with membrane antigens ofhuman erythrocytes / F.H. Guo, X.M. Yan, C.X. Fan et all // World J. Gastroenterol.– 2007. – N 13. – P. 3742-46.306. Gupta A.K. Endothelial dysfunction: an early cardiovascular risk marker in asymptomatic obese individuals with prediabetes / A.K.
Gupta, E. Ravussin, D.L.Johannsen et all // Br. J. Med. Med. Res. – 2012. – Vol. 2, N3. – P. 413-23.307. Gupta S. Elevated Chlamydia pneumoniae antibodies, cardiovascular events andazithromycin in male survivors of myocardial infarction / S. Gupta, E.W. Leatham,D. Carrington // Circulation. – 1997. – N 96. – P. 404-407.308.
Gurevich V.S. Influenza, autoimmunity and atherogenesis / V.S. Gurevich //Autoimmun. Rev. – 2005. – Vol. 4, N 2. – P. 101-105.309. Haberle H.A. Differential stimulation of IL-12 and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma-interferonproducing T cells in human gastric mucosa / H.A. Haberle, M.
Kubin, K.B. Bamfordet all // Infect. Immun. – 1997. – N 65. – P. 4229-35.310. Haim M. Soluble intercellular adhesion molecule-1 and long-term risk of acutecoronary events in patients with chronic coronary heart disease. Data from theBezafibrate Infarction Prevention (BIP) Study / M. Haim, D. Tanne, V. Boyko et all// J.
Am. Coll. Cardiol. – 2002. – N 39. – P. 1133-38.311. Hansson G.K. The immune response in atherosclerosis: a double-edged sword /G.K. Hansson, P. Libby // Nat. Rev. Immunol. – 2006. – N 6. – P. 508-19.312. Hansson G.K. Innate and adaptive immunity in the pathogenesis of atherosclerosis/ G.K. Hansson, P. Libby, U. Schonbeck, Z.Q. Yan // Circ. Res. – 2002.
– N 91. – P.281-91.313. Harris P.R. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production / P.R. Harris, H.L. Mobley,G.I. Perez-Perez et all // Gastroenterology. – 1996. – N 111. – P. 419-25.314. Harrison D. Role of oxidative stress in atherosclerosis / D. Harrison, K.K.Griendling, U. Landmesser et all // Am. J.
Card. – 2003. – Vol. 91, N 3. – P. 7-11.385315. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction /D.G. Harrison // J. Clin. Invest. – 1997. – N 100. – P. 2153-57.316. Hartmann F. Biochemical markers in diagnosis of coronary artery disease / F.Hartmann, M. Kampmann, N. Frey // Eur. Heart J. – 1998. – N 19 (Suppl.) – P. N2N7.317. Healy A.M.
Platelet expression profiling and clinical validation of myeloid-relatedprotein-14 as a novel determinant of cardiovascular events / A.M. Healy, M.D. Pickard, A.D. Pradhan et all // Circulation. – 2006. – N 113. – P. 2278-84.318. Heinecke J.W. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis / J.W. Heinecke // Am. J. Card. – 2007.
– Vol. 91, N 3. – P. 12-16.319. Hendrix M.G. High prevalence of latently present cytomegalo virus in arterialwalls of patients suffering from grade III atherosclerosis / M.G. Hendrix, M.M.Salimans, C.P. van Bowen, C.A. Bruggeman // Am. J. Pathol. – 1990. – N 136.
– P.23-28.320. Herrera M.D. Endothelial dysfunction and aging: an update / M.D. Herrera, C.Mingorance, R. Rodríguez-Rodríguez, M. Alvarez de Sotomayor // Ageing Res. Rev.– 2010. – Vol. 9, N 2. – P. 142-52.321. Hoffmeister A. Current infection with Helicobacter pylori, but not seropositivity toChlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile / A. Hoffmeister, D. Rothenbacher, G. Bode, K. Persson et all //Arterioscler.
Tromb. Vasc. Biol. – 2001. – Vol. 21, N 3. – P. 427-32.322. Hofman V. Effect of Helicobacter pilory on polymorphonuclear leukocite migration across polarized Т84 epithelial cell monolayers: role of vacuolating toxin VасАand cag pathogenicity island / V.
Hofman, V. Ricci, A. Galmiche et all // Infect. andImmun. – 2000. – N 68. – P. 5225-33.323. Holmgren J. Mucosal immunity and vaccination / J. Holmgren // FEMS Microbiology Letters – 1991. – Vol. 89, N 1. – P. 1-9.324. HolschermannH.Pathophysiologyofacutecoronarysyndrome/H.Holschermann, H. Tillmanns, С. Вode // Hamostaseol. – 2006. – N 26. – P. 99-103.386325.
Holvoet P. Oxidized lipoproteins in atherosclerosis and thrombosis / P. Holvoet, D.Collen // FASEB J. – 1994. – Vol. 8, N 15. – P. 1279-84.326. Hoogeveen R.С. Plasma МСР-1 level and risk for peripheral arterial disease andincident coronary heart disease: Atherosclerosis Risk in Communities Study / R.С.Hoogeveen, А. Morrison, F. Boerwinkle et all // Atherosclerosis. – 2005. – Vol. 183,N 2. – P. 301-307.327. Hu H. The atherogenic effect of chlamydia are dependent on serum cholesterol andspecific to chlamydia pneumonia / H. Hu, G.N.
Pierce, G. Zhong // J. Clin. Invest. –1999. – N 103. – P. 747-53.328. Humphrey L.L. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis / L.L. Humphrey, R. Fu, K. Rogers et all // Mayo.Clin. Proc. – 2008. – Vol. 83, N 11. – P. 1203-12.329. Hung H.H. Immunoglobulin G antibody against Helicobacter pylori is an accuratetest for atrophic gastritis / H.H. Hung, T.S. Chen, H.C. Lin // J. Chin. Med. Assoc. –2010. – Vol.
73, N 7. – P. 355-59.330. Hunt S.C. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis / S.C. Hunt, G. Lambert, M.J. Amar et all // J. Biol. Chem. – 2003. – N 278. –P. 2563-70.331. Ibrahim A.I. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barrvirus DNA in atherosclerotic plaques and in unaffected bypass grafts / A.I. Ibrahim,M.T. Obeid, M.J.
Jouma et all // J. Clin. Virol. – 2005. – Vol. 32, N 1. – P. 29-32.332. Ieven M.M. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence / M.M. Ieven, V.Y. Hoymans // J. Clin. Microbiol. –2005. – Vol. 43, N 1. – P. 19-24.333. Innocenti M. Helicobacter pylori-induced activation of human endothelial cells /M. Innocenti, A.C. Thoreson, R.L. Ferrero // Infect. Immun. – 2002.
– N 70. – P.4581-90.387334. Jackson L.A. Specificity of detection of Chlamydia pneumoniac in cardiovascularatheroma: evaluation of the innocent bystander hypothesis / L.A. Jackson, L.A.Campbell, R.A. Schmidt et all // Am. J.Pathol. – 1997. – N 150. – P. 1785-90.335. Jafarzadeh A. Serum concentrations of Helicobacter pylori IgG and the virulencefactor CagA in patients with ischemic heart disease / A. Jafarzadeh, A. EsmaeeliNadimi, M. Nemati et all // East Mediterr Health J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
